(Reuters) - William Ackman's Pershing Square Capital Management said it had filed a lawsuit seeking confirmation that a requested special shareholder meeting of Allergan Inc's shareholders would not trigger Allergan's poison pill takeover defense. The Botox maker has rejected a $53 billion joint offer from Ackman and Canadian drugmaker Valeant Pharmaceuticals International. Allergan said in April that its board had adopted a one-year shareholder rights plan to give it more time to consider takeover proposals. Allergan's shareholder rights plan will trigger if a person or group acquires 10 percent or more of its shares.
from Business News Headlines - Yahoo! News http://ift.tt/1hPP18i
via
IFTTT
No comments:
Post a Comment